-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

702. CAR-T Cell Therapies: Basic and Translational: Poster II

Symposia: CAR-T Cell Therapies: Basic and Translational Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 8, 2024: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Zeguang Wu1*, Jinhong Shi2*, Qiezhong Lamao1*, Jinxin Yang1*, Yuanyuan Qiu1*, Yang Liu2*, Feifei Liang3*, Changya Chen4, Qingming Yang2*, Chunmeng Wang2*, Haixia Zhang3*, Zhonghan Yang3*, Yunyi Zhang3*, Yuting Yi3*, Xufen Zheng3*, Yun Sun3*, Kuiying Ma5*, Lingling Yu5*, Huihui Yang5*, Yongjian Zhang3*, Zhiqiang Wu2*, Yao Wang2*, Zhenguang Wang3*, Catherine CL Wong1*, Pengfei Yuan, PhD3*, Weidong Han2* and Wensheng Wei1*

1Peking University, Beijing, China
2The First Medical Center, Chinese PLA General Hospital, Beijing, China
3EdiGene Inc, Beijing, China
4Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
5Changping Laboratory, Beijing, China

Sanam Shahid, MD1, Serena Mathew2*, Sydney Souness2*, Erin R. Burns2*, Jasmine S. Um2*, Sarah Yoo2*, Winson Cai2*, Mary Ann Pohl3*, Takeshi Fujino2*, Pu Zhang2*, Jennifer Lewis2*, Sean M. Devlin, PhD4*, Ivo Lorenz3*, Renier Brentjens, MD PhD5 and Anthony F. Daniyan, MD6*

1Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY
2Memorial Sloan Kettering Cancer Center, New York, NY
3Tri‐Institutional Therapeutics Discovery Institute, Memorial Sloan Kettering Cancer Center, New York, NY
4Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY
5Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY
6Department of Medicine, Cell Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY

Meijuan Huang, MD1*, Lei Zhao, MD, PhD2*, Yuhang Cheng2*, Liang Huang2, Jianfeng Zhou, MD, PhD2*, Dengju Li, PhD2, Jue Wang2* and Yang Cao3*

1Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China, Wuhan, China
2Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
3Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, San Diego, CA

Eleni Gavriilaki, MD, PhD1,2, Christos Demosthenous, MD3*, Zoi Bousiou, MD2*, Ioannis Batsis, MD2*, Anna Vardi, MD3*, Despina Mallouri, MD4*, Evdoxia Koravou5*, Nikolaos Spyridis, MD3*, Alkistis Kyra Panteliadou, MD3*, Georgios Karavalakis, MD3*, Paschalis Evangelidis6*, Marianna Masmanidou7*, Tasoula Touloumenidou8*, Apostolia Papalexandri, MD3*, Christos Poziopoulos, MD9*, Ioanna Sakellari, MD3*, Marianna Politou10* and Ioannis Papassotiriou, PhD11

1Aristotle University of Thessaloniki, Thessaloniki, Greece
2Hematology Department – BMT Unit, George Papanikolaou General Hospital, Thessaloniki, Greece
3Hematology Department – BMT Unit, G Papanicolaou Hospital, Thessaloniki, Greece
4German Oncology Center, Limassol, Cyprus, Thessaloniki, Greece
5Hematology Department & HCT Unit, G. Papanicolaou Hospital, Thessaloniki, GRC
6Second propedeutic department of internal medicine, Hippokration Hospital, Thessaloniki, Greece, Thessaloniki, Greece
7Hematology Dept. - BMT Unit, George Papanicolaou General Hospital, Thessaloniki, Greece
8Hematology Department-BMT Unit, Georgios Papanikolaou General Hospital, Thessaloniki, Greece
9Department of Hematology, Metropolitan Hospital, Neo Faliro, Greece
10National and Kapodistrian University of Athens, Medical School, Athens, GRC
11First Department of Pediatrics, National and Kapodistrian University of Athens, School of Medicine, Athens, Attica, Greece

Devang Thakkar1*, Brian T. Hill, MD, PhD2, Rachel Kositsky3*, Shari Tian3*, Leonardo Biral3*, Veronica Russell3*, Tushar Dave3*, Cassandra L. Love3, Caroline Roth3*, Matthew Stuart McKinney, MD4, Ahmed Galal, MD5, Jadee Neff, MD, PhD4*, Agrima Mian, MD, MBBS6, Ellen Kendall7*, Sarah L. Ondrejka, DO8, Matthew Chiaramonte, BA9*, Govind Bhagat, MD10, Kenneth N. Ofori, MHS, MD11*, Ran Reshef, MD, MSc12, Alexandra E. Kovach, MD13*, Tarsheen Sethi, MD, MSc14, Emily F. Mason, MD, PhD15*, Shakthi Bhaskar, MD16, Olalekan O. Oluwole, MD, MPH, MBBS16, Chad McCall17*, Christopher Pallas, MD18*, Nilanjan Ghosh, MD, PhD18, Robert Ferdman, MD19*, George Chen, MD19, Francisco Hernandez-Ilizaliturri, MD20, Joanna Zurko, MD21, Ashley Cunningham, MD22*, Nirav C Shah, MD23*, Boyu Hu, MD24, Deborah M. Stephens, DO24, Monalisa Ghosh, MD25, Neil Bailey, MSc26, Krish Patel, MD27, John M. Pagel, MD, Ph.D, DSc26, Kavya Kannamma Kannan, MBBS28*, Eric D. Hsi, MD29, Rakhee Vaidya, MD30*, Andrew Ip, MD31*, Andre Goy, MD, MS32, Swetha Kambhampati Thiruvengadam, MD33, Robert Ohgami, MD, PhD34*, Charalambos Andreadis, MD35, Christian A Gordillo, BS36*, Brianna Just37*, Jonathon B Cohen, MD MS38, Arielle Baim39*, Julie Barbello26*, Erika Cavallone40*, Veronika Bachanova, MD, PhD41, Maureen Laschen42*, Andinet Teferra42*, Frederique Lorcy43*, Sylvain Lamure, MD, PhD44*, Guillaume Cartron, MD, PhD45*, Valerie Dardalhon, PhD46*, Kikkeri N Naresh47, Magdalena Czader, MD, PhD48*, Anupama Reddy49*, Elizabeth Thacker50*, Clayton Parker, MS50*, Lanie Happ50* and Sandeep Dave, M.D.4*

1Department of Medicine, Duke University, Durham, NC
2Department of Hematology and Medical Oncology, Taussig Cancer Institute, The Cleveland Clinic Foundation, Cleveland, OH
3Duke University, Durham, NC
4Duke University Medical Center, Durham, NC
5Duke University School of Medicine, Durham, NC
6Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
7National Heart, Lung, and Blood Institute, Bethesda, MD
8Department of Pathology and Laboratory Medicine, Cleveland Clinic, Cleveland, OH
9Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY
10Department of Pathology & Cell Biology, Columbia University, New York, NY
11Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York
12Division of Hematology & Oncology, Columbia University Medical Center, New York
13Vanderbilt University, Nashville, TN
14Hematology, Yale University School of Medicine, New Haven, CT
15Department of Pathology, Microbiology, Immunology, Vanderbilt University Medical Center, Nashville, TN
16Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN
17Atrium Health Carolinas, Charlotte, NC
18Levine Cancer Institute, Charlotte, NC
19Roswell Park Comprehensive Cancer Center, Buffalo, NY
20Roswell Park Comprehensive Cancer Center, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY
21MCW Cancer Center, Medical College of Wisconsin, Madison, WI
22Department of Pathology, Medical College of Wisconsin, Milwaukee, WI
23MCW Cancer Center, The Medical College of Wisconsin, Milwaukee, WI
24Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
25University of Michigan, Ann Arbor, MI
26Swedish Cancer Institute, Seattle, WA
27Swedish Cancer Institute, Center for Blood Disorders and Cellular Therapy, Seattle, WA
28Wake Forest University, Winston-Salem, NC
29Department of Pathology, Wake Forest Baptist Medical Center, Winston Salem, NC
30Wake Forest, Winston-Salem, NC
31Hackensack Meridian School of Medicine, John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, NJ
32John Theurer Cancer Center, Hackensack, NJ
33City of Hope National Medical Center, Yorba Linda, CA
34ARUP Institute for Research and Innovation, Salt Lake City, UT
35Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, CA
36Blood and Marrow Transplantation and Cell Therapy Program, Columbia University Irving Medical Center, New York, NY
37University of Wisconsin Carbone Cancer Center, Madison, WI
38Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA
39Medical College of Wisconsin, Milwaukee, WI
40UCSF, San Francisco, CA
41Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN
42Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN
43CHU Montpellier, Montpellier, FRA
44IGMM UMR 5535 CNRS UM, University of Montpellier, MONTPELLIER, France
45Centre Hospitalier Universitaire de Montpellier, Montpellier, France
46Institut de Génétique Moléculaire de Montpellier, University of Montpellier, Montpellier, France
47Fred Hutchinson Cancer Center, Seattle, WA
48Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN
49Vindhya Data Science, Morrisville, NC
50Data Driven Bioscience, Durham, NC

Dasom Lee, MD1, Brian J. Sworder, MD, PhD2, Lara Stepan, BS3*, Abood Okal, PhD4*, Chang-Pin Huang3*, Xiaoman Kang, BS5*, James Hamilton6*, Charles Macaulay5*, Mari Olsen, BS7*, Chih Long Liu, PhD7*, Maximilian Diehn, MD, PhD8*, Leanne Peiser, DPhil3*, David Kurtz, MD, PhD9 and Ash A. Alizadeh, MD, PhD7

1Department of Medicine, Division of Oncology, Stanford University, Redwood City, CA
2Division of Hematology and Oncology, University of California, Irvine, Irvine, CA
3Bristol Myers Squibb, Seattle, WA
4Bristol Myers Squibb, Cambridge, MA
5Department of Medicine, Division of Oncology, Stanford University, Stanford, CA
6Department of Molecular Biology, UT Southwestern Medical Center, Dallas
7Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA
8Department of Radiation Oncology, Stanford University, Stanford, CA
9Department of Medicine (Oncology), Stanford University, Palo Alto, CA

Zineng Huang1*, Hao Xu2*, Qingbai Liu3*, Jing Li4*, Keqing Song5*, Yating Deng1*, Yujia Tao1*, Huifang Zhang1*, Peilong Wang1*, Heng Li, MD1*, Yue Sheng, PhD1, Aijun Zhou3*, Lianbin Han6*, Yan Fu6*, Chenzhi Wang6*, Saurav Kumar Choudhary7*, Kaixiong Ye7*, Gianluca Veggiani8*, Avery August9*, Zhihong Li10*, Weishan Huang8*, Qiang Shan2*, Hongling Peng, MD1* and Zheng Fu6*

1Department of Hematology, The Second XIANGYA Hospital, Changsha, China
2National Key Laboratory of Immunity and Inflammation, Suzhou Institute of Systems Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Suzhou, China
3Lianshui People's Hospital of Kangda College Affiliated to Nanjing Medical University, Huai’an, China
4Key Laboratory of Cluster Science, Ministry of Education of China, School of Chemistry and Chemical Engineering, Beijing, China
5Tianjin Mogenetics Biotech Co., Ltd, Tianjin, China
6MegaRobo Technologies Co., Ltd, Suzhou, China
7Institute of Bioinformatics, University of Georgia, Athens
8Department of Pathobiological Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge
9Department of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca
10Department of Orthopedics, The Second XIANGYA Hospital, Changsha, China

Cai Zihong1*, Baiwei Luo1*, Bailin He1*, Li Xuan1*, Qifa Liu, MD1 and Hongsheng Zhou2,3,4*

1Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China
2Department of Hematology,Nanfang Hospital, Southern Medical University, Guangzhou, China
3Guangdong Provincial Clinical Research Center for Hematologic Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China
4Department of Hematology, People's Hospital of Ganzhou, Ganzhou, China

Grace Hawkins1*, Danielle Kirkey, MD1,2*, Nika Panahi, BS1*, Melia Blankenfeld, BS1*, Isabel Lira, BS1*, Tiffany Hylkema, BS1*, Cyd McKay1*, Christina Root1*, Jack H. Peplinski, MSc1*, Logan K. Wallace, MSc1*, Rhonda E. Ries, MA1*, Laura Pardo, MS3*, Michael R. Loken, PhD3* and Soheil Meshinchi, MD, PhD1

1Translational Science and Therapeutics, Fred Hutchinson Cancer Center, Seattle, WA
2Division of Hematology and Oncology, Seattle Children's Hospital, Seattle
3Hematologics, Inc., Seattle, WA

Roberto Garcia-Vicente1*, Alba Rodríguez García2*, Raquel Ancos-Pintado3*, Andrés Arroyo Barea4*, Adriana Ortega-Hernandez5*, Irene Bragado-Garcia3*, Eva Castellano1*, Alejandra Ortiz-Ruiz6*, Miguel Angel Navarro-Aguadero3*, Javier Modrego5*, Alejandra Leivas, PhD1*, José Sanchez-Pina7*, Rafael Alonso Fernandez, MD7*, Maria Hernandez-Sanchez8*, Mariateresa Fulciniti, PhD9, Cecilia Carpio10*, Pere Barba, MD11, Diego Carbonell12*, Mi Kwon, MD, PhD13, Mariana Bastos-Oreiro14*, Alejandro Martín García-Sancho15*, Ana Jiménez Ubieto16*, Antonio Valeri, PhD7*, Dulcenombre Gomez-Garre17*, Joaquín Martínez-Lopez7* and María Linares18*

1Department of Translational Hematology, Research Institute Hospital 12 de Octubre (i+12), Hematological Malignancies Clinical Research Unit H120-CNIO, CIBERONC, Madrid, Spain
2Department of Translational Hematology, Research Institute Hospital 12 de Octubre (i+12), Hematological Malignancies Clinical Research Unit H120-CNIO, CIBERONC, Madrid, Spain, Madrid, ESP
3Department of Translational Hematology, Research Institute Hospital 12 De Octubr, Madrid, ESP
4Hospital Universitario 12 De Octubre, Imas12 Madrid, Madrid, ESP
5Microbiota and Vascular Biology Laboratory, Hospital Clínico San Carlos-Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain
6Hospital 12 de Octubre, Madrid, Spain
7Department of Hematology, Hospital Universitario 12 de Octubre, Spanish National Cancer Research Center (CNIO), Complutense University Madrid, Madrid, Spain
8Department of Biochemistry and Molecular Biology, Pharmacy School, Universidad C, Madrid, ESP
9Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA
10Department of Hematology, Vall d'Hebron Institute of Oncology (VHIO), University Hospital Vall d'Hebron, Autonomous University of Barcelona (UAB), Barcelona, Spain
11Deparment of Hematology, Vall Hebron Institute of Oncology (VHIO), Hospital Universitari Vall D'Hebron, La Garriga, Barcelona, Spain
12Department of Hematology, Gregorio Marañón University Hospital, Instituto de Investigación Sanitaria Gregorio Marañón,, Madrid, Madrid, ESP
13General University Hospital Gregorio Marañón, Madrid, Spain
14Hematology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain
15Hematology Department, Hospital Universitario de Salamanca, IBSAL, CIBERONC, University of Salamanca, Salamanca, Spain
16Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain
17Microbiota and Vascular Biology Laboratory, Hospital ClíNico San Carlos-I, Madrid, ESP
18Universidad Complutense de Madrid, Madrid, Spain

Niklas Deschl1,2,3,4*, Viktoria Blumenberg, MD5,6,7,8,9, Maria-Luisa Schubert, MD10*, Anita Schmitt, MD10*, Michael Schmitt, MD10*, Marion Subklewe, MD7,11,12,13 and Christoph Stein-Thoeringer, MD1,2,3,4*

1Laboratory for Translational Microbiome Sciences, University Hospital Tuebingen, Tuebingen University, Tuebingen, Germany
2M3 Institute, University Hospital Tuebingen, Tuebingen University, Tuebingen, Germany
3Department of Internal Medicine I, University Hospital Tuebingen, Tuebingen University, Tuebingen, Germany
4Cluster of Excellence "Controlling Microbes to Fight Infections" (CMFI), Tuebingen University, Tuebingen, Germany
5Department of Medicine III, University Hospital LMU Munich, Munich, Germany, Munich, Germany
6Department of Medicine III, University Hospital LMU Munich, Munich, Germany
7German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany
8Cellular Immunotherapy Program, Massachusetts General Hospital and Harvard Medical School, Boston, MA
9Laboratory for Translational Cancer Immunology, LMU Gene Center, LMU Munich, Munich, Germany
10Department of Medicine V, University Hospital Heidelberg, Heidelberg, Germany
11Laboratory for Translational Cancer Immunology, LMU Gene Center, Munich, Germany
12Bavarian Cancer Research Center (BZKF), Munich, Germany
13Department of Medicine III, LMU University Hospital, Munich, Germany

Haley M. Simpson, MD, PhD1, Amanda Novak, BS2*, Catherine Danis, PhD3, Michael Yarnell, BSc4*, Phoebe Duong5*, Brett M Stevens, PhD, BS6*, Craig T Jordan, PhD6 and M. Eric Kohler, MD, Ph.D7

1Division of Hematology, University of Colorado, Aurora, CO
2Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, CO
3University of Colorado, Anschutz Medical Campus, Aurora, CO
4University of Colorado Anschutz Medical Campus, Aurora, CO
5University of Colorado, Aurora
6Division of Hematology, University of Colorado Anschutz Medical Campus, Aurora, CO
7Division of Hematology/Oncology/Bone Marrow Transplant and Center for Cancer and Blood Disorders, Ch, Aurora, CO

Melia Blankenfeld, BS1*, Danielle C. Kirkey, MD1,2, Guangyan Xiong3*, Hongbing Zhang3*, Grace Hawkins1*, Isabel Lira, BS1*, Cyd McKay1*, Christina Root1*, Concetta Quintarelli, PhD4*, Franco Locatelli, MD4, Cheng Liu, PhD3* and Soheil Meshinchi, MD, PhD1

1Translational Science and Therapeutics, Fred Hutchinson Cancer Center, Seattle, WA
2Pediatric Hematology/Oncology, Seattle Children's Hospital, Seattle, WA
3Eureka Therapeutics, Emeryville, CA
4IRCCS Bambino Gesù Children's Hospital, Rome, Italy

Emily Wolf, MD1, Madiha Iqbal, MD1, Zhuo Li, MS2*, Han W. Tun, MD1 and Ephraim E. Parent, MD, PhD3*

1Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL
2Division of Biomedical Statistics and Informatics, Mayo Clinic, Jacksonville
3Department of Radiology, Mayo Clinic, Jacksonville, FL

Yuanyuan Zhang1,2*, Meijuan Huang, MD1,2*, Tianjiao Liu, MD, PhD3*, Yuhang Cheng1,2*, Dengju Li, PhD1,2, Yang Cao2,4*, Wei Mu1,2*, Liting Chen, PhD1,2*, Li Zhu, MD, PhD1,2*, Tongjuan Li, MD, PhD1,2*, Liang Huang, MD, PhD5,6, Jia Wei1,2, Lei Zhao, MD, PhD1,2* and Jue Wang1,2*

1Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
2Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, China
3Department of Hematology and Oncology, Ningbo No.2 Hospital, Zhejiang Province, Ningbo, China
4Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, San Diego, CA
5State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin, China
6Tianjin Institutes of Health Science, Tianjin, China

Wenjing Luo1,2*, Jia Xu1,2*, Chenggong Li1,2*, Lu Tang1*, Yingying Li1,3*, Xindi Wang1,2*, Wu Zhuolin1,2*, Yinqiang Zhang1,2*, Yu Hu1,2* and Heng Mei, md, phd1,2*

1Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
2Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease, Wuhan, China
3Hubei Clinical and Research Centre of Thrombosis and Haemostasis, Wuhan, China

Viktor Lemgart1*, Jennifer Richards2*, Laura Strauss2*, Jing Jiao2*, Brandon Quido2*, Laura Powers2*, Allison Caron1*, Eyoung Shin1*, Austin Boesch2*, Dharini Shah2*, Tiffany Le1*, Rasika Kunden1*, Samantha Stewart1*, Fazila Nasimi1*, Sampa Maiti1*, Mir Ali1*, Olga Lihoradova1*, Aaron Griset1*, Christopher M. Borges1, William Kuhlman1*, Carla Lawendowski2*, Ulrik Nielsen2*, Valeria Fantin2*, Daryl Drummond1*, Donald Shaffer2* and Andrew J Sawyer3*

1Genetic Medicines Unit, Sanofi, Cambridge, MA
2Oncology Research, Sanofi, Cambridge, MA
3Oncology Research, Sanofi, North Reading, MA

Erik L Kimble, MD1,2, Salvatore Fiorenza, MBBS, PhD, BSc, FRACP, FRCPA, MPH3,4, Alexandre V. Hirayama, MD5,6, Austin M Gabel, BS7*, Jordan Gauthier, MD, MSc2,8, Aiko Torkelson, BS8*, Abigail Chutnik, BS8*, Henna Di, BS8*, Jocelyn H Wright, PhD8*, Barbara Pender, MSc8*, Stefan Radtke, PhD8, Roland B. Walter, MD, PhD, MS8,9, Hans-Peter Kiem, MD, PhD1,2, David G. Maloney, MD, PhD8, Robert K. Bradley, PhD10,11* and Cameron J. Turtle, MBBS, PhD5,12*

1Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA
2University of Washington, Seattle, WA
3Faculty of Medicine and Health, University of Sydney, Balwyn North, VIC, Australia
4Molecular Oncology and Cancer Immunology, Epworth HealthCare, Richmond, VIC, Australia
5Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
6Division of Hematology and Oncology, University of Washington, Seattle, WA
7University of Washington, School of Medicine, Seattle, WA
8Fred Hutchinson Cancer Center, Seattle, WA
9Department of Medicine, Division of Hematology and Oncology, University of Washington, Seattle, WA
10Basic Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA
11Department of Genome Sciences, University of Washington, Seattle, WA
12University of Sydney, Sydney, NSW, Australia

Ana Belén Moreno-Castaño, MD1*, Sara Fernández2*, Helena Brillembourg3*, Blanca de Moner4,5*, Helena Ventosa-Capell6*, Julia Martinez-Sanchez, PhD7*, Alex Ramos8*, Marta Palomo, PhD9*, Patricia Molina4*, Marc Pino4*, Pilar Gomez-Ramirez10*, Valentin Ortiz-Maldonado, MD, PhD, MSc11,12,13,14,15, Nuria Martínez-Cibrián, MD16*, Julio Delgado, MD, PhD3,17*, Carlos Fernández de Larrea, MD18, Maria Queralt Salas Gay, MD19*, Alvaro Urbano-Ispizua, MD, PhD3,14,17, Adrián Téllez20*, Jose Maria Nicolas21*, Ginés Escolar22*, Enric Carreras, MD, PhD23*, Francesc Fernández-Avilés, MD, PhD24,25*, Pedro Castro20* and Maribel Diaz-Ricart, PhD7*

1Hemostasis and Erythropathology Laboratory. Pathology Department, Hematopathology. Centre de Diagnòstic Biomèdic. University of Barcelona. IDIBAPS, BARCELONA, Spain
2Medical Intensive Care Unit, Clínic Barcelona. University of Barcelona, IDIBAPS., Hospital Clínic, Barcelona, Barcelona, ESP
3Hematology Department, Hospital Clínic de Barcelona, Barcelona, Spain., Barcelona, Spain
4Hemostasis and Erythropathology, Hematopathology, Pathology Department, CDB, IDIBAPS, University of Barcelona, Hospital Clínic, Barcelona, Spain
5Josep Carreras Leukaemia Research Institute, Barcelona, Spain
6Medical Intensive Care Unit, Clínic Barcelona, Barcelona, Spain. Hospital Clinic Barcelona, Barcelona, ESP
7Hemostasis and Erythropathology, Hematopathology, Pathology Department, CDB, IDIBAPS, University of Barcelona, Hospital Clínic de Barcelona, Barcelona, Spain
8Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS. Hospital Clinic de Barcelona, Barcelona, Spain
9Hematology External Quality Assessment Laboratory, Centre de Diagnòstic Biomèdic, Hospital Clínic Barcelona, Spain., BARCELONA, Spain
10Laboratory of Hemostasis and Erythropathology, Hematopathology, Pathology Departm, Barcelona, ESP
11Hematology Department, Hematology Department, Hospital Clínic Barcelona, Barcelona, Spain, Barcelona, ESP
12Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
13Hematology Department, Hospital Clínic Barcelona, Barcelona, Spain, Seattle, WA
14University of Barcelona, Barcelona, Spain
15Hospital Clínic de Barcelona, Barcelona, Spain
16Hematology Department, Hospital Clínic Barcelona, Barcelona, Spain, Barcelona, Spain
17Fundació de Recerca Clínic Barcelona-Institut D’Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain
18Hematology Department., Hospital Clínic de Barcelona, IDIBAPS., Barcelona, Spain
19Hematology Department, Hospital Clínic de Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain., BARCELONA, Spain
20Medical Intensive Care Unit, IDIBAPS, University of Barcelona, Hospital Clínic, Barcelona, Spain
21Medical Intensive Care Unit, Hospital Clinic, Barcelona, ESP
22Hemostasis and Erythropathology Laboratory, Hematopathology, Pathology Department, CDB, Hospital Clinic, IDIBAPS. University of Barcelona, Barcelona, Spain
23Fundació Josep Carreras Contra la Leucèmia, Barcelona, Spain
24Fundació de Recerca Clínic Barcelona-Institut d’Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Barcelona, Spain
25Hematopoietic Transplantation Unit, Hematology Department, Clinical Institute of Hematology and Oncology (ICMHO), Hospital Clínic de Barcelona, Barcelona, Spain

Tommaso Balestra, PhD1, Lisa M Niswander, MD, PhD1,2, Asen Bagashev, PhD1*, Joseph P Loftus1*, Savannah L Ross3*, Robert K Chen1*, Samantha M McClellan1*, Jacob J Junco4,5*, Diego Alberto Barcenas-Lopez, PhD1, Karen R Rabin, MD, PhD5,6, Terry J Fry, MD3,7 and Sarah K Tasian, MD2,8,9

1Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA
2Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, PA
3Division of Hematology/Oncology/Bone Marrow Transplant and Center for Cancer and Blood Disorders, Children’s Hospital of Colorado, Aurora, CO
4Department of Pediatrics, Baylor College of Medicine, Houston, TX
5Cancer Center and Division of Pediatric Hematology/Oncology, Texas Children’s Hospital, Houston, TX
6Department of Pediatrics, Division of Pediatric Hematology/Oncology, Baylor College of Medicine, Houston, TX
7Immunology Department and HI3 Initiative, University of Colorado Anschutz Medical Campus, Aurora, CO
8University of Pennsylvania School of Medicine, Philadelphia, PA
9Division of Oncology & Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA

Viktoria Blumenberg, MD1,2,3,4, Maryam Kazerani, PhD5, Tobias Straub, Ph.D.6*, Francesco Corrado, MD3,7*, Vadim Borisov8*, Stephan Baumann3*, Galina Busch3*, Jan Wulf3*, Agnese Petrera, PhD9*, Kai Rejeski, MD2,3,10,11, Christian Schmidt, MD12*, Benjamin Tast3*, Michael von Bergwelt-Baildon, MD, PhD2,13*, Christoph Stein-Thöringer8,14*, Veit L. Buecklein, MD2,3,10* and Marion Subklewe, MD2,3,10

1Department of Medicine III, University Hospital LMU Munich, Munich, Germany
2German Cancer Consortium (DKTK) and Bavarian Cancer Research Center (BZKF), partner site Munich, Munich, Germany
3Laboratory for Translational Cancer Immunology, LMU Gene Center, LMU Munich, Munich, Germany
4Cellular Immunotherapy Program, Massachusetts General Hospital and Harvard Medical School, Boston, MA
5Laboratory for Translational Cancer Immunology, Cedars-Sinai Medical Center, Los Angeles, CA
6Core Facility Bioinformatics, LMU Biomedical Center, LMU Munich, Munich, Germany
7Department of Medical Oncology, Jerome Lipper Center for Multiple Myeloma Research, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA
8Internal Medicine I, Laboratory for Translational Microbiome Sciences, University Clinic Tübingen, Tübingen, Germany
9Metabolomics and Proteomics Core, Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Neuherberg, Germany
10Department of Medicine III, LMU University Hospital, Munich, Germany
11Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY
12Department of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany
13Department of Medicine III, University Hospital, LMU Munich, Munich, Germany
14Cluster of Excellence, Controlling Microbes to Fight Infections (CMFI), University Tübingen, Tübingen, Germany

Roberto Savoldelli, PhD1*, Alice Pievani, PhD2*, Sarah Tettamanti3*, Chiara Giacomini, PhD1*, Anna Kozlowska, PhD4*, Marta Serafini5* and Francesco Dazzi6,7*

1King's College London, London, United Kingdom
2Centro Ricerca M. Tettamanti, Department of Pediatrics, University of Milan Bicocca, Monza, ITA
3"Matilde Tettamanti" Research Center, Monza, ITA
4Biopharma Cell Therapy R&D, AstraZeneca, Gothenburg, Sweden
5DIMET, University of Milano-Bicocca, Monza, ITA
6School of Cardiovascular and Metabolic Medicine and Sciences, King's College London, London, United Kingdom
7AstraZeneca Biopharma R&D, Cambridge, United Kingdom

Juliet Crabtree1*, Akinola Emmanuel1*, Ganapathy Subramanian Sankaran1*, Jui Dutta-Simmons1*, Karolina Kosakowska1*, Tracy Dimezzo1*, Ian Langer1*, Prapti Vyas1*, David Soto1*, Akshi Thakkar1*, Grace Chen1*, Maja Sedic1*, Scott Barros1*, Allen Horhota1*, Isin Dalkilic-Liddle1*, LT Thiruneelakantapillai1*, Muthusamy Jayaraman1*, Megan Hoban1*, Frank Neumann1 and Robert Mabry, PhD2*

1Orna Therapeutics, Watertown, MA
2Orna Therapeutics, Cambridge, MA

Ajlan Al Zaki, MD, PhD1, Margie Sutton, PhD2*, Abdur Rehman, PhD3*, Cao Cuong Le, PhD4*, Seth Gammon, PhD5*, Arianna Napoli6*, Ping Yang6*, Neeraj Y. Saini, MD7, Sairah Ahmed, MD8, Ghayas C. Issa, MD9, Partow Kebriaei, MD7, Michael Davies, MD, PhD10*, Elizabeth J. Shpall, MD7, Jeena Varghese, MD11*, Lesley Flynt, MD12*, Sattva S. Neelapu, MD3 and David Piwnica-Worms, MD, PhD5*

1Department of Lymphoma/Myeloma and Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX
2Cancer Systems Imaging, Assistant Professor, Houston
3Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
4Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston
5Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX
6Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston
7Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
8Department of Lymphoma/Myeloma and Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, Houston, TX
9Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
10The University of Texas MD Anderson Cancer Center, Houston
11Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston
12Department of Nuclear Medicine, The University of Texas MD Anderson Cancer Center, Houston

Zoe O'Connor, MD1, Ashley Bui, MD1*, Laura Coughlin, MA1*, Shuheng Gan, MS1*, Samuel John, MD2*, Nicole Poulides, MS1*, Parastoo Sabaeifard, PhD1*, Xiaowei Zhan, PhD1*, Stephen Lim, MD3*, Angelica Sanjuan, MS4*, Theodore W. Laetsch, MD5* and Andrew Y. Koh, MD6*

1University of Texas Southwestern Medical Center, Dallas, TX
2Department of Pediatrics, Division of Hematology-Oncology, University of Texas Southwestern Medical Center, Dallas, TX
3Novartis Pharmaceuticals Corporation, East Hanover, NJ
4University of Texas at Dallas, Dallas, TX
5Department of Pediatrics and Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
6Dept. of Pediatrics; Division of Hematology-Oncology, UT Southwestern Medical Center, Dallas, TX

Ciril Abraham, BS1,2*, Wenbin Mo, MMSc1*, Tien Bui3*, Mimi Chen, PhD1*, Yuanyuan Tian, PhD1*, Gennaro Clando4*, Morgan Chaunzwa4*, Ying WANG5*, Jozef Madzo4*, Jean-Pierre Issa4* and Yi Zhang, MD, PhD1

1Center for Discovery and Innovation, Hackensack University Medical Center, Nutley, NJ
2Fels Institute and Department of Cancer Cellular Biology, Lewis Katz School of Medicine, Temple University, Nutley, NJ
3Center for Discovery and Innovation, Hackensack University Medical Center, Nutley
4Coriell Institute for Medical Research, Camden, NJ
5Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, NJ

Joseph Durgin, MD1*, Shadab Kazmi, PhD2*, Andre Kelly2*, Roddy S. O'Connor, PhD2* and Saba Ghassemi, PhD2

1Department of Dermatology, University of Michigan, Ann Arbor, MI
2Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA

Showkat Hamid, MD1, Muhammad Junaid Tariq, MBBS2*, SaeBom Lee, PhD2*, Payal Goala, MS, BS2*, Shannon McSain1*, Cooper Sailer, PhD, MS2*, Nolan Beatty2* and Marco Davila, MD, PhD1

1Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY
2Roswell Park Cancer Institute, Buffalo, NY

Yue Liu, PhD1*, Lingna An2* and Xi Zhang, PhD3

1Medical Center of Hematology; Xinqiao Hospital of Army Medical University, Chongqing 400037, China, Chongqing, China
2Medical Center of Hematology; Xinqiao Hospital of Army Medical University, Chongqing 400037, China., chongqing, China
3Medical Center of Hematology, Xinqiao Hospital of Army Medical University, State Key Laboratory of Trauma and Chemical Poisoning, Chongqing Key Laboratory of Hematology and Microenvironment, Chongqing, China

*signifies non-member of ASH